These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32805059)

  • 1. Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with intravenous immunoglobulin: 'Killing 2 birds with one stone'.
    Saha M; D'Cruz A; Paul N; Healy R; Collins D; Charles DA; Sahu S; Fonia A
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):e97-e98. PubMed ID: 32805059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
    Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
    Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levofloxacin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Teo WL; Pang SM
    Ann Acad Med Singap; 2010 Aug; 39(8):660-1. PubMed ID: 20838711
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is intravenous immunoglobulin effective in toxic epidermal necrolysis and Stevens-Johnson syndrome?].
    Navajas L; Rada G
    Medwave; 2014 Oct; 14(9):e6024. PubMed ID: 25340656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin: a series of three cases.
    Comparin C; Hans Filho G; Takita LC; Costa Nde C; Nascimento RA; Nanni Lde O
    An Bras Dermatol; 2012; 87(3):477-81. PubMed ID: 22714769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases.
    Kara A; Devrim İ; Çağlar İ; Bayram N; Kundak S; Apa H; Altan EV
    Turk J Pediatr; 2019; 61(4):538-543. PubMed ID: 31990471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stevens-Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulins].
    Yuste M; Sánchez-Estella J; Santos JC; Alonso MT; Bordel MT; Gutiérrez JL; Zamora T
    Actas Dermosifiliogr; 2005 Nov; 96(9):589-92. PubMed ID: 16476303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic epidermal necrolysis treatment and outcomes: a retrospective analysis of 10 patients treated with intravenous immunoglobulin.
    Mehregan D; Van Vreede A; Goralewski M
    Int J Dermatol; 2016 Jun; 55(6):e356-60. PubMed ID: 26694974
    [No Abstract]   [Full Text] [Related]  

  • 9. Research in Stevens-Johnson syndrome/toxic epidermal necrolysis (TEN): a network of specialist TEN centres is needed to undertake effective clinical studies and therapeutic trials.
    Creamer D; Walsh S
    Br J Dermatol; 2013 Dec; 169(6):1177. PubMed ID: 24299527
    [No Abstract]   [Full Text] [Related]  

  • 10. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Kühn-Córdova I; Ramírez-Bouchan D; Gamboa-Marrufo JD
    An Pediatr (Barc); 2007 Jul; 67(1):68-73. PubMed ID: 17663910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ofloxacin eyedrops-induced toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Parmar NV; Kuruvila S; Ganguly S; Krishna CV
    Int J Dermatol; 2014 Nov; 53(11):e547-8. PubMed ID: 25209837
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of intravenous immunoglobulin in toxic epidermal necrolysis.
    Feldmeyer L; Kerdel FA; French LE
    Arch Dermatol; 2011 Dec; 147(12):1440-1. PubMed ID: 22184768
    [No Abstract]   [Full Text] [Related]  

  • 14. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
    Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
    J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin in the treatment of childhood Stevens Johnson syndrome.
    Britton P; Deng L
    J Paediatr Child Health; 2011 Jun; 47(6):392-5. PubMed ID: 21649751
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic epidermal necrolysis in oncologic patients.
    Gravante G; Delogu D; Esposito G; Montone A
    Am J Clin Dermatol; 2006; 7(6):397-8. PubMed ID: 17173477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.